ScreenerHero

QNTM Quantum BioPharma Ltd.

NAS · US · Healthcare · Biotechnology · quantumbiopharma.com
3.145USD+1.78%Mkt Cap: 20.22M $P/E: —

Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. The company operates through two segments, Biopharmaceutical Innovation and Strategic Investments. It researches and develo…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap20.22M USD
Enterprise Value20.24M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-26.18M USD
Revenue/Share—
Last Price3.145 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees—
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.40
PEG—
EV/EBITDA-1.72
EV/Revenue—
P/S—
P/B2.95
EPS (TTM)-4.98
EPS (Forward)-7.80
52W Range
2.0706% of range19.30
52W High19.30 USD
52W Low2.070 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-378.01%
ROA-234.53%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-8.24M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-24.88%
Net Debt-2.89M USD
Net Debt/EBITDA0.25
Balance Sheet
Debt/Equity0.27
Current Ratio1.20
Quick Ratio0.48
Book Value/Sh1.05 USD
Cash/Share0.48 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:65
Split DateAug 15, 2024
Analyst Consensus
Rating—
Target (Mean)12.28 USD
Upside (mean)+290.3%
Target Range12.28 USD – 12.28 USD
# Analysts1
Ownership
Shares Out.6.43M
Float7.63M
Insiders8.40%
Institutions9.61%
Short Interest
Short Ratio1.1d
Short % Float3.24%
Short % Out.3.00%
Shares Short242.50K
Short (prev mo.)291.17K
Technical
SMA 503.362 (-6.5%)
SMA 2004.385 (-28.3%)
Beta0.38
S&P 52W Chg15.78%
Avg Vol (30d)208.22K
Avg Vol (10d)237.22K
Technical Indicators
RSI (14)41.6
MACD-0.0175
MACD Signal0.0564
MACD Hist.-0.0739
BB Upper4.082 USD
BB Middle3.518 USD
BB Lower2.954 USD
BB Width32.07%
ATR (14)0.3081 USD
Vol Ratio (20d)0.63x